zolmitriptan has been researched along with scopolamine hydrobromide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bansod, P; Swathi, KP; Tripathi, AS | 1 |
1 review(s) available for zolmitriptan and scopolamine hydrobromide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for zolmitriptan and scopolamine hydrobromide
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Activation of 5-HT 1b/d receptor restores the cognitive function by reducing glutamate release, deposition of β-amyloid and TLR-4 pathway in the brain of scopolamine-induced dementia in rat.
Topics: Amyloid beta-Peptides; Animals; Antioxidants; Brain; Cognition; Cognitive Dysfunction; Dementia; Disease Models, Animal; Glutamic Acid; Glutathione; Glutathione Peroxidase; Maze Learning; Memory Disorders; Oxazolidinones; Oxidative Stress; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Scopolamine; Serotonin; Serotonin 5-HT1 Receptor Agonists; Superoxide Dismutase; Toll-Like Receptor 4; Tryptamines | 2021 |